ocular antibiotics and anti-infectives regis p. kowalski, ms, m(ascp) research professor of...

16
Ocular Antibiotics and Antibiotics and Anti-Infectives Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell Laboratory University of Pittsburgh, Pittsburgh, PA The Charles T. Campbell The Charles T. Campbell Ophthalmic Microbiology Ophthalmic Microbiology Laboratory Laboratory

Upload: ross-richard

Post on 17-Dec-2015

217 views

Category:

Documents


1 download

TRANSCRIPT

Page 1: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

Ocular Antibiotics Ocular Antibiotics and Anti-Infectivesand Anti-Infectives

Regis P. Kowalski, MS, M(ASCP)

Research Professor of Ophthalmology

Executive Director of The Charles T Campbell Laboratory

University of Pittsburgh, Pittsburgh, PA

The Charles T. Campbell The Charles T. Campbell Ophthalmic Microbiology Ophthalmic Microbiology LaboratoryLaboratory

Page 2: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

Areas of Infection

Page 3: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

Per

cent

Inc

iden

ce

0

10

20

30

40

50

60

Newborns Children Adults

No growth

StreptococcusCoagulase-negative staphylococcusDiphtheroidsStaphylococcus aureusGram negatives

Normal Flora

Page 4: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

Distribution of Bacteria Isolated from Endophthalmitis (1993-2010) (N=518)

Staphylococcus aureus - 10.5% (54)

Other GramPositives - 4.8% (25)

Streptococcusspecies - 19.5% (101)

Coagulase NegativeStaphylococcus 57.7% (299)

Other GramNegatives - 7.5% (39)

Gram-positives = 92.5%Gram-negatives = 7.5%

Page 5: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

Treatment AdministrationTreatment Administration

Topical Topical – Most common (conjunctivitis, – Most common (conjunctivitis, keratitis, blepharitis, prophylaxis)keratitis, blepharitis, prophylaxis)

Intra-vitreal injectionIntra-vitreal injection – endophthalmitis – endophthalmitis

SystemicSystemic – not commonly used – not commonly used

SubconjunctivalSubconjunctival – used to provide a – used to provide a constant flow of anti-infective to ocular constant flow of anti-infective to ocular surface.surface.

Page 6: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

AntibacterialsAntibacterials

Antibiotics – No Topical Standards for Interpreting Antibiotics – No Topical Standards for Interpreting SusceptibilitySusceptibility

Use Serum Systemic Susceptibility Standards - Use Serum Systemic Susceptibility Standards - But we must assume that But we must assume that “The antibiotic “The antibiotic concentrations reached in the ocular tissue by concentrations reached in the ocular tissue by topical therapy is equal to or greater than the topical therapy is equal to or greater than the concentration of antibiotic in the blood serum”.concentration of antibiotic in the blood serum”.

Ocular antibiotics are developed from systemic Ocular antibiotics are developed from systemic antibiotics for conjunctivitis, keratitisantibiotics for conjunctivitis, keratitis

Page 7: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

Antibiotics ParametersAntibiotics Parameters

Concentration–dependentConcentration–dependent

fluoroquinolones, aminoglycosidesfluoroquinolones, aminoglycosides Time-dependentTime-dependent

vancomycin, cefazolinvancomycin, cefazolin Bactericidal – killBactericidal – kill

FQs, vancomycin,FQs, vancomycin, BacteristaticBacteristatic – inhibit – inhibit

erythromycin, azithromycin, sulfaerythromycin, azithromycin, sulfa AntisepticsAntiseptics – PI – kill immediately – PI – kill immediately

Page 8: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

MIC

MBC

MPC

Growth

No growth but viable

Death but possible mutations

Death and NO mutations

Susceptibility Parameters

Page 9: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

Nature of Resistance of BacteriaNature of Resistance of Bacteria

A function of the anti-infective A function of the anti-infective mechanism,mechanism,

Target bacteria,Target bacteria, The ocular tissue, and The ocular tissue, and The treatment regimen.The treatment regimen.

Page 10: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

Problem with ResistanceProblem with Resistance

Organism acquires resistance to an Organism acquires resistance to an antibiotic.antibiotic.

Resistance spreads to other patientsResistance spreads to other patients No antibiotic to cover resistanceNo antibiotic to cover resistance

Page 11: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

Class Mode of Action Primary Indicationbesides conjunctivitis

Fluoroquinolones DNA synthesis keratitis, surgical prophylaxis(ciprofloxacin, ofloxacin, bactericidal Broad-spectrum coveragelevofloxacin, gatifloxacin,moxifloxacin) besifloxacin

Aminoglycosides protein synthesis keratitis, endophthalmitis(gentamicin, tobramycin, cell wall surgical prophylaxisamikacin) bactericidal Broad-spectrum coverage

Cephalosporins cell wall keratitis, endophthalmitis(cefazolin, ceftazidime) bactericidal Gram-positive coverage

Glycopeptides cell wall keratitis, endophthalmitis(vancomycin) bactericidal MRSA prophylaxis

Gram-positive coverage

Macrolides protein synthesis blepharitis(erythromycin, azithro) bacteristatic Gram-positive coverage

Peptides cell wall blepharitis, keratitis(bacitracin, polymycin B) bactericidal Bac – GMpos PB – GMneg

Sulfa drugs enzyme inhibitor keratitis, 2nd – line MRSA(sulfacetamide) bacteristatic Broad-spectrum coverage

Page 12: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

Anti-Infective Test BatteriesAnti-Infective Test Batteries

KeratitisKeratitis EndophthalmitisEndophthalmitis ConjunctivitisConjunctivitisbacitracinbacitracin vancomycinvancomycin bacitracinbacitracinvancomycinvancomycin gentamicingentamicin erythromycinerythromycinciprofloxacinciprofloxacin ciprofloxacinciprofloxacin gentamicingentamicinofloxacinofloxacin ofloxacinofloxacin ciprofloxacinciprofloxacinpolymyxin Bpolymyxin B cefazolincefazolin ofloxacinofloxacincefazolincefazolin amikacinamikacin trimethoprimtrimethoprimtobramycintobramycin ceftazidimeceftazidime polymyxin Bpolymyxin Bsulfisoxazolesulfisoxazole cefoxitincefoxitin tobramycintobramycincefoxitincefoxitin ampicillinampicillin sulfisoxazolesulfisoxazolegentamicingentamicin clindamycinclindamycin azithromycinazithromycingatifloxacingatifloxacin gatifloxacingatifloxacin gatifloxacingatifloxacinmoxifloxacinmoxifloxacin moxifloxacinmoxifloxacin moxifloxacinmoxifloxacin

Page 13: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

Antifungal DrugsAntifungal Drugs

Page 14: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell
Page 15: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

Acanthamoeba DrugsAcanthamoeba Drugs Cationic Antiseptics (Chlorhexidine Cationic Antiseptics (Chlorhexidine

and PHMB)and PHMB) Aromatic diamides (propamidine)Aromatic diamides (propamidine)

Page 16: Ocular Antibiotics and Anti-Infectives Regis P. Kowalski, MS, M(ASCP) Research Professor of Ophthalmology Executive Director of The Charles T Campbell

Thank You !!